Alpa Laboratories Limited

BSE: 532878 NSE: ALPA
Alpa Laboratories Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN L85195MP1988PLC004446 Incorporated 18 March 1988 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Listed - NSE: ALPA · BSE: 532878 Public Limited Company pharma MSME
Data last updated
Revenue · FY 2025-26
₹105.81 Cr
▼ 5.9% YoY
EBITDA · FY 2025-26
₹3.29 Cr
▼ 30.6% YoY
Net profit · FY 2025-26
₹15.01 Cr
▼ 23.1% YoY
Net worth · FY 2025-26
₹186.28 Cr
Latest filings
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹21.04 Cr
Issued & subscribed
Open charges
₹26 Cr
Satisfied ₹81.73 Cr
Company age
38 yrs
Est. 1988

About Alpa Laboratories Limited

Data last updated:

Alpa Laboratories Limited is a public limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 March 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN L85195MP1988PLC004446. Its GSTIN is 23AACCA8437C2Z2 (Madhya Pradesh). The company holds 7 GST registrations, of which 4 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 532878 and NSE: ALPA.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹21.04 Cr. It was formerly known as Alpa Laboratories Private Limited. It is led by directors including Mahendra Singh Chawla (Whole-Time Director) and Pravin Chandra Shah (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 33/2 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹105.81 Cr, a decline of 5.9% compared to the previous year. For the same year it recorded a net profit of ₹15.01 Cr (net margin 14.2%) and EBITDA of ₹3.29 Cr (EBITDA margin 3.1%). The net worth stands at ₹186.28 Cr (up 8.2% YoY). Total assets are valued at ₹188.79 Cr (up 9.6% YoY).

The company has about 367 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 2 brands: Alpa Labs and Alpa Labs. As per MCA filings, the company has open charges of ₹26 Cr and satisfied charges of ₹81.73 Cr on record. Court records list 39 cases involving the company, including 15 filed by the company and 24 filed against it; 4 cases are pending. The company has 44 deals on record (42 market trades, 1 acquisition, 1 ipo); the latest was in September 2024. Its 10 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Palsons Derma Private Limited with revenue of ₹137.11 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2020, listing 129 overdue payments to 3 micro and small suppliers.

Alpa Laboratories Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MP-23-0015817). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alpalabs.in.

Company details

CIN L85195MP1988PLC004446
Registration Number 004446
Incorporation Date 18 March 1988
ROC Gwalior
Listing Status Listed - Listed on NSE (ALPA); Listed on BSE (532878)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MP-23-0015817

CIN history

Alpa Laboratories has one previous CIN (Corporate Identification Number): U85195MP1988PLC004446. The current CIN is L85195MP1988PLC004446, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85195MP1988PLC004446Current
U85195MP1988PLC004446Previous
Key People
Mahendra Singh Chawla Whole-Time Director Pravin Chandra Shah Whole-Time Director Shitul Shah Whole-Time Director

Recognitions & Rankings of Alpa Laboratories

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MP-23-0015817

Contact details

Alpa Laboratories Limited's registered office is in Indore, Madhya Pradesh. Its website is alpalabs.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    alpalabs.in
  • Social Media
  • Registered Address
    33/2 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Alpa Laboratories Limited, buy the company report.

Comprehensive company report
Alpa Laboratories Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Alpa Laboratories operates two associated brands: Alpa Labs and Alpa Labs. Each brand links to its own profile.

BrandDescriptionWebsite
Alpa Labs
Generic drugs manufacturer & exporteralpalabs.com
Alpa Labs
Alpa Labs is engaged in manufacturing pharmaceutical dosage forms.alpalabs.in

Business activity

The main business activity of Alpa Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Alpa Laboratories Limited, buy the company report.

Financials of Alpa Laboratories Limited

FY 2025-26 filings available

Alpa Laboratories Limited reported revenue of ₹105.81 Cr (down 5.9% YoY) for FY 2025-26.

Revenue · FY 2025-26
₹105.81 Cr ▼ 5.9%
Profit · FY 2025-26
₹15.01 Cr ▼ 23.1%
Computed EBITDA · FY 2025-26
₹3.29 Cr ▼ 30.6%
Revenue₹ Cr · Consolidated050100150FY 2019-20: ₹86 Cr86FY 2019-20FY 2020-21: ₹98 Cr · +13.5% YoY97.6+13.5%FY 2020-21FY 2021-22: ₹112 Cr · +15.1% YoY112+15.1%FY 2021-22FY 2022-23: ₹93 Cr · -17.2% YoY93-17.2%FY 2022-23FY 2023-24: ₹109 Cr · +17% YoY109+17%FY 2023-24FY 2024-25: ₹112 Cr · +3.4% YoY112+3.4%FY 2024-25FY 2025-26: ₹106 Cr · -5.9% YoY106-5.9%FY 2025-26
Net Profit₹ Cr · Consolidated01020FY 2019-20: ₹3 Cr2.6FY 2019-20FY 2020-21: ₹5 Cr · +97.3% YoY5.2+97.3%FY 2020-21FY 2021-22: ₹8 Cr · +49.5% YoY7.7+49.5%FY 2021-22FY 2022-23: ₹13 Cr · +63% YoY12.6+63%FY 2022-23FY 2023-24: ₹17 Cr · +36.6% YoY17.2+36.6%FY 2023-24FY 2024-25: ₹20 Cr · +13.5% YoY19.5+13.5%FY 2024-25FY 2025-26: ₹15 Cr · -23.1% YoY15-23.1%FY 2025-26
Quarterly Revenue₹ Cr · vs same quarter last year02040Sep 2024: ₹25 Cr24.9Sep 2024Dec 2024: ₹26 Cr26.2Dec 2024Mar 2025: ₹40 Cr39.9Mar 2025Jun 2025: ₹19 Cr · -10.9% YoY19.1-10.9%Jun 2025Sep 2025: ₹26 Cr · +5.3% YoY26.3+5.3%Sep 2025Dec 2025: ₹29 Cr · +11.1% YoY29.1+11.1%Dec 2025Mar 2026: ₹31 Cr · -21.3% YoY31.4-21.3%Mar 2026Jun 2026: ₹24 Cr · +25.2% YoY23.9+25.2%Jun 2026
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue from Operations₹105.81 Cr₹112.45 Cr₹108.74 Cr₹92.96 Cr₹112.27 Cr₹97.55 Cr₹85.97 Cr
Other Income₹15.76 Cr₹23.35 Cr₹14.89 Cr₹9.37 Cr₹10.78 Cr₹4.4 Cr₹2.91 Cr
Cost of Materials Consumed-₹71.65 Cr₹68.68 Cr₹53.67 Cr₹69.24 Cr₹60.62 Cr₹51.42 Cr
Employee Benefit Expense-₹14.39 Cr₹13.29 Cr₹12.17 Cr₹11.93 Cr₹11.75 Cr₹11.82 Cr
Finance Costs₹26 Lakh₹23 Lakh₹36 Lakh₹22 Lakh₹22 Lakh₹8 Lakh₹20 Lakh
Depreciation & Amortisation₹2.09 Cr₹2.2 Cr₹1.95 Cr₹1.33 Cr₹1.66 Cr₹1.23 Cr₹3.16 Cr
Other Expenses-₹10.91 Cr₹8.65 Cr₹7.07 Cr₹8.29 Cr₹7.56 Cr₹8.8 Cr
Total Expenses₹102.52 Cr₹107.71 Cr₹100.64 Cr₹84.88 Cr₹101.6 Cr₹89.87 Cr₹82.63 Cr
Profit Before Tax₹16.7 Cr₹25.66 Cr₹20.68 Cr₹15.9 Cr₹19.57 Cr₹10.77 Cr₹2.89 Cr
Total Tax Expense₹1.69 Cr₹6.17 Cr₹3.9 Cr₹3.31 Cr₹5.47 Cr₹3.54 Cr₹1.06 Cr
Net Profit₹15.01 Cr₹19.53 Cr₹17.21 Cr₹12.6 Cr₹7.73 Cr₹5.17 Cr₹2.62 Cr
EBITDA (computed)₹3.29 Cr₹4.74 Cr₹8.1 Cr₹8.08 Cr₹10.67 Cr₹7.68 Cr₹3.34 Cr
Basic EPS₹6.71₹9.27₹7.97₹5.98₹6.70₹3.44₹0.88
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Total Assets₹188.79 Cr₹172.18 Cr₹157.16 Cr₹136.88 Cr₹127.58 Cr₹107.83 Cr₹100.78 Cr
Current Assets₹75.86 Cr₹81.99 Cr₹69.84 Cr₹77.09 Cr₹69.32 Cr₹80.39 Cr₹56.17 Cr
Property, Plant & Equipment₹20.16 Cr₹21.36 Cr₹11.47 Cr₹7.04 Cr₹9.32 Cr₹7.21 Cr₹6.4 Cr
Inventories₹13.33 Cr₹17.64 Cr₹13.67 Cr₹12.64 Cr₹15.46 Cr₹16.56 Cr₹12.55 Cr
Trade Receivables₹40.83 Cr₹46.83 Cr₹41.15 Cr₹46.73 Cr₹38.04 Cr₹35.43 Cr₹24.59 Cr
Cash & Equivalents₹2.85 Cr₹2.22 Cr₹1.71 Cr₹8.81 Cr₹1.58 Cr₹10.51 Cr₹6.17 Cr
Equity (Net Worth)₹186.28 Cr₹172.14 Cr₹151.91 Cr₹134.58 Cr₹121.73 Cr₹107.64 Cr₹100.37 Cr
Equity Share Capital₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr
Total Debt (computed)₹2.51 Cr₹3 Lakh₹5.25 Cr₹2.3 Cr₹5.85 Cr₹19 Lakh₹41 Lakh
Current Liabilities₹50.02 Cr₹46.67 Cr₹22.82 Cr₹28.1 Cr₹27.66 Cr₹32.32 Cr₹20.56 Cr
Total Liabilities₹188.79 Cr₹172.18 Cr₹157.16 Cr₹136.88 Cr₹127.58 Cr₹107.83 Cr₹100.78 Cr
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Operating Cash Flow₹9.29 Cr₹18.32 Cr₹3.65 Cr₹8.9 Cr₹9.94 Cr-₹1.71 Cr₹17.78 Cr
Investing Cash Flow-₹10.88 Cr-₹12.36 Cr-₹13.34 Cr₹2.13 Cr-₹15.61 Cr₹5.86 Cr-₹11.16 Cr
Financing Cash Flow₹2.22 Cr-₹5.44 Cr₹2.58 Cr-₹3.79 Cr₹5.44 Cr₹19 Lakh-₹1.35 Cr
Net Change in Cash₹63 Lakh₹51 Lakh-₹7.1 Cr₹7.24 Cr-₹23 Lakh₹4.34 Cr₹5.27 Cr
MetricsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue from Operations₹23.93 Cr₹31.4 Cr₹29.05 Cr₹26.26 Cr₹19.11 Cr₹39.92 Cr₹26.15 Cr₹24.94 Cr₹21.44 Cr
Other Income₹5.77 Cr-₹16 Lakh₹91 Lakh₹3.06 Cr₹11.94 Cr₹2.48 Cr₹8.8 Cr₹6.91 Cr₹5.16 Cr
Total Income₹23.93 Cr₹31.4 Cr₹29.05 Cr₹26.26 Cr₹19.11 Cr₹39.92 Cr₹26.15 Cr₹24.94 Cr₹21.44 Cr
Finance Costs₹11 Lakh₹15 Lakh₹3 Lakh₹3 Lakh₹5 Lakh₹2 Lakh₹9 Lakh₹5 Lakh₹5 Lakh
Depreciation & Amortisation₹72 Lakh₹22 Lakh₹65 Lakh₹67 Lakh₹55 Lakh₹58 Lakh₹55 Lakh₹53 Lakh₹54 Lakh
Profit Before Tax₹98 Lakh₹3.07 Cr₹1.74 Cr₹12 Lakh₹11.76 Cr₹2.08 Cr₹8.9 Cr₹9.65 Cr₹5.1 Cr
Total Tax Expense₹0₹1.69 Cr₹16 Lakh₹0₹0₹4.2 Cr₹0₹1.96 Cr₹0
Net Profit₹98 Lakh₹1.38 Cr₹1.58 Cr₹12 Lakh₹11.76 Cr-₹2.12 Cr₹8.9 Cr₹7.69 Cr₹5.1 Cr
EBITDA (computed)-₹3.96 Cr₹3.6 Cr₹1.51 Cr-₹2.24 Cr₹42 Lakh₹20 Lakh₹74 Lakh₹3.32 Cr₹53 Lakh
Basic EPS₹0.49₹0.24₹0.76₹0.05₹5.59₹-0.95₹4.23₹3.66₹2.42
Latest 9 quarters shown.
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue from Operations₹105.81 Cr₹112.45 Cr₹108.74 Cr₹92.96 Cr₹112.27 Cr₹97.55 Cr₹85.97 Cr
Other Income₹15.72 Cr₹23.31 Cr₹14.87 Cr₹9.41 Cr₹10.79 Cr₹4.41 Cr₹2.97 Cr
Cost of Materials Consumed-₹71.65 Cr₹68.68 Cr₹53.67 Cr₹69.24 Cr₹60.62 Cr₹51.42 Cr
Employee Benefit Expense-₹14.37 Cr₹13.26 Cr₹12.17 Cr₹11.93 Cr₹11.75 Cr₹11.82 Cr
Finance Costs₹29 Lakh₹27 Lakh₹39 Lakh₹22 Lakh₹24 Lakh₹10 Lakh₹20 Lakh
Depreciation & Amortisation₹2.09 Cr₹2.2 Cr₹1.95 Cr₹1.33 Cr₹1.66 Cr₹1.23 Cr₹1.14 Cr
Other Expenses-₹10.9 Cr₹8.64 Cr₹7.42 Cr₹8.29 Cr₹7.56 Cr₹8.79 Cr
Total Expenses₹102.51 Cr₹107.45 Cr₹100.6 Cr₹84.88 Cr₹101.57 Cr₹89.86 Cr₹82.53 Cr
Profit Before Tax₹16.64 Cr₹25.84 Cr₹20.67 Cr₹15.94 Cr₹19.59 Cr₹10.77 Cr₹5.07 Cr
Total Tax Expense₹1.69 Cr₹6.16 Cr₹3.9 Cr₹3.31 Cr₹5.45 Cr₹3.53 Cr₹1 Cr
Net Profit₹14.95 Cr₹19.72 Cr₹17.2 Cr₹12.64 Cr₹7.76 Cr₹5.14 Cr₹5.38 Cr
EBITDA (computed)₹3.3 Cr₹5 Cr₹8.14 Cr₹8.08 Cr₹10.7 Cr₹7.69 Cr₹3.44 Cr
Basic EPS₹6.69₹9.35₹7.97₹6.00₹6.71₹3.45₹1.94
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Total Assets₹198.09 Cr₹181.84 Cr₹167.22 Cr₹147.71 Cr₹137.49 Cr₹117.71 Cr₹110.64 Cr
Current Assets₹73.72 Cr₹80.96 Cr₹68.64 Cr₹76.77 Cr₹68.11 Cr₹79.19 Cr₹55 Cr
Property, Plant & Equipment₹20.16 Cr₹20.65 Cr₹11.47 Cr₹7.04 Cr₹9.32 Cr₹7.21 Cr₹6.4 Cr
Inventories₹13.33 Cr₹17.64 Cr₹13.67 Cr₹12.64 Cr₹15.46 Cr₹16.56 Cr₹12.55 Cr
Trade Receivables₹40.83 Cr₹46.83 Cr₹41.15 Cr₹47.37 Cr₹38.04 Cr₹35.43 Cr₹24.59 Cr
Cash & Equivalents₹1.21 Cr₹1.68 Cr₹1.26 Cr₹8.74 Cr₹1.31 Cr₹10.24 Cr₹5.92 Cr
Equity (Net Worth)₹196.58 Cr₹181.8 Cr₹161.97 Cr₹145.11 Cr₹131.64 Cr₹117.52 Cr₹110.23 Cr
Equity Share Capital₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr₹21.04 Cr
Total Debt (computed)₹1.51 Cr₹3 Lakh₹5.25 Cr₹2.59 Cr₹5.85 Cr₹19 Lakh₹41 Lakh
Current Liabilities₹49.95 Cr₹46.66 Cr₹22.8 Cr₹28.1 Cr₹25.08 Cr₹32.3 Cr₹20.56 Cr
Total Liabilities₹198.09 Cr₹181.84 Cr₹167.22 Cr₹147.71 Cr₹137.49 Cr₹117.71 Cr₹110.64 Cr
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Operating Cash Flow₹9.95 Cr₹18.39 Cr₹3.7 Cr₹10.2 Cr₹2.2 Cr-₹1.47 Cr₹17.66 Cr
Investing Cash Flow-₹11.58 Cr-₹12.49 Cr-₹13.45 Cr₹1.17 Cr-₹15.61 Cr₹5.82 Cr-₹11.27 Cr
Financing Cash Flow₹1.16 Cr-₹5.48 Cr₹2.26 Cr-₹3.48 Cr₹5.41 Cr-₹3 Lakh-₹1.35 Cr
Net Change in Cash-₹47 Lakh₹43 Lakh-₹7.49 Cr₹7.89 Cr-₹7.99 Cr₹4.32 Cr₹5.03 Cr
MetricsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue from Operations₹23.93 Cr₹31.4 Cr₹29.67 Cr₹25.63 Cr₹19.11 Cr₹39.11 Cr₹26.15 Cr₹24.94 Cr₹21.44 Cr
Other Income₹5.83 Cr-₹18 Lakh₹26 Lakh₹3.69 Cr₹11.96 Cr₹3.24 Cr₹8.8 Cr₹6.91 Cr₹5.18 Cr
Total Income₹23.93 Cr₹31.4 Cr₹29.67 Cr₹25.63 Cr₹19.11 Cr₹39.11 Cr₹26.15 Cr₹24.94 Cr₹21.44 Cr
Finance Costs₹11 Lakh₹16 Lakh₹3 Lakh₹5 Lakh₹5 Lakh₹5 Lakh₹10 Lakh₹6 Lakh₹5 Lakh
Depreciation & Amortisation₹72 Lakh₹22 Lakh₹65 Lakh₹67 Lakh₹55 Lakh₹58 Lakh₹55 Lakh₹53 Lakh₹54 Lakh
Total Expenses₹27.89 Cr₹27.78 Cr₹27.53 Cr₹28.5 Cr₹18.69 Cr₹39.47 Cr₹25.41 Cr₹21.67 Cr₹20.9 Cr
Profit Before Tax₹1.04 Cr₹3.06 Cr₹1.72 Cr₹10 Lakh₹11.78 Cr₹2.25 Cr₹8.89 Cr₹9.59 Cr₹5.13 Cr
Total Tax Expense₹0₹1.69 Cr-₹16 Lakh₹0₹0₹4.2 Cr₹0₹1.96 Cr₹0
EBITDA (computed)-₹3.96 Cr₹3.62 Cr₹2.14 Cr-₹2.87 Cr₹42 Lakh-₹36 Lakh₹74 Lakh₹3.27 Cr₹54 Lakh
Latest 9 quarters shown.

To see the full year-wise statements and ratios of Alpa Laboratories Limited, buy the company report.

Board of directors of Alpa Laboratories Limited

Alpa Laboratories has 9 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mahendra Singh Chawla
Also directs: Norfolk Mercantile Private Limited
Whole-Time Director18 Mar 198838 Years 7 MonthsCurrent
Pravin Chandra Shah
Also directs: Norfolk Mercantile Private Limited
Whole-Time Director01 Mar 200917 Years 7 MonthsCurrent
Paresh Chawla
Also directs: Norfolk Mercantile Private Limited, Seabright Landmark Projects LLP
Director28 May 201610 Years 5 MonthsCurrent
Vitthal KothanaDirector13 Aug 20224 Years 2 MonthsCurrent
Pratik ShahDirector31 Aug 20242 Years 1 MonthsCurrent
Shitul Shah
Also directs: Wealthpile Trading LLP
Whole-Time Director14 Aug 20233 Years 2 MonthsCurrent
Showing 6 of 9 current directors. View all directors

Peer comparison

Alpa Laboratories Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Palsons Derma Private Limited₹137.11 Cr (FY 2025)15.0%Kolkata, West Bengal, India
Maxwell Life Science Limited₹136.55 Cr (FY 2025)67.0%Mumbai, Maharashtra, India
Lewens Labs Private Limited₹136.52 Cr (FY 2025)12.0%Bharuch, Gujarat, India
Naari Pharma Private Limited₹136.35 Cr (FY 2025)14.0%Bangalore, Karnataka, India
Zenith Drugs Limited₹135.93 Cr (FY 2025)2.0%Indore, Madhya Pradesh, India
Ravoo's Laboratories Limited₹134.97 Cr (FY 2024)4.0%Hyderabad, Telangana, India
Surabhi Industries (India) Private Limited₹133.75 Cr (FY 2024)-37.0%Hyderabad, Telangana, India
Vikram Thermo (India) Limited₹133.72 Cr (FY 2025)5.0%Ahmedabad, Gujarat, India
Strassenburg Pharmaceuticals Private Ltd.₹133.69 Cr (FY 2025)13.0%Kolkata, West Bengal, India
Hemmo Pharmaceuticals Private Limited₹133.32 Cr (FY 2021)45.0%Mumbai, Maharashtra, India
Alpa Laboratories Limitedthis company₹105.81 Cr (FY 2026)₹15.01 Cr14.2%-5.9%367Indore, Madhya Pradesh, India

To see the full peer comparison of Alpa Laboratories Limited, buy the company report.

Auditor

Alpa Laboratories Limited is audited by C.H. Padliya & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
C.H. Padliya & Co.FY 2024003151C

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 57.20%, foreign institutional investors hold 0.40%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 42.40%.

Promoters: 57.20%FII (Foreign Institutional): 0.40%Retail & Others: 42.40%
Sep 2026
QUARTER
57.20% Promoters
0.40% FII (Foreign Institutional)
42.40% Retail & Others
Promoter holding - history
Now 57.20% · Sep 2026High 57.30% · Dec 2025Low 57.20% · Jun 2026
56%56.8%57.5%58.3%59%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 57.30%Mar 2026: 57.30%Jun 2026: 57.20%Sep 2026: 57.20%57.30%57.20%57.20%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters57.20%57.20%57.30%57.30%
Public42.80%42.80%42.70%42.70%

Charges & borrowings

Open charges
₹26 Cr
Satisfied charges
₹81.73 Cr
Breakdown by lending institutions
Others₹14.00 Cr
Hdfc Bank Limited₹12.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Jul 2025101142713Hdfc Bank Limited₹7 CrOpen
06 Jan 2024100845955Hdfc Bank Limited₹5 CrOpen
06 Dec 2017100139390Others₹14 CrOpen
24 Apr 2019100262538Yes Bank Limited₹10 CrSatisfied
01 Sep 2017100134584Hdfc Bank Limited₹37 LakhSatisfied

To see the full charge records of Alpa Laboratories Limited, buy the company report.

Total charge records: 13 View all charges

Deals & funding

Alpa Laboratories Limited has 44 deals on record (42 market trades, 1 acquisition, 1 ipo); the latest was in September 2024.

Total deals
44
Market trades
42
Acquisition
1
IPO
1

Deals on record (5 of 44)

WhenDealAmountParties
Sep 2024Market trade₹16.56 CrBuyer: Aakraya Research LLP , Qe Securities LLP , NK Securities Research Private Limited
Seller: Aakraya Research LLP , Qe Securities LLP , NK Securities Research Private Limited
Sep 2024Market trade₹2.4 CrBuyer: NK Securities Research Private Limited
Seller: NK Securities Research Private Limited
Sep 2024Market trade₹1.34 CrBuyer: Hrti Private Limited
Seller: Hrti Private Limited
Sep 2024Market trade₹3.77 CrBuyer: NK Securities Research Private Limited , Hrti Private Limited , Qe Securities LLP
Seller: NK Securities Research Private Limited , Qe Securities LLP , Hrti Private Limited
Feb 2024Market trade₹1.31 CrBuyer: Citadel Securities India Markets Private Limited
Seller: Citadel Securities India Markets Private Limited

To see the full deal history of Alpa Laboratories Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Alpa Laboratories Limited was last rated by Crisil on 28 Dec 2020.

Rating agencyRated onRating
Crisil28 Dec 2020

To see the full credit ratings and regulatory alerts of Alpa Laboratories Limited, buy the company report.

MSME payment delays

Alpa Laboratories Limited has 5 MSME Form 1 returns on record between 2019 and 2020, listing 129 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (3 of 3)

SupplierAmount dueDue sinceReported on
Doer Packaging Private Limited
Indiana Chem-Port
Bhasin Packwell Pvt Ltd

To see the full MSME payment records of Alpa Laboratories Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Alpa Laboratories has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Norfolk Mercantile Private LimitedU74120MH2014PTC252923

To see the full group structure of Alpa Laboratories Limited, buy the company report.

Employees & EPFO

Alpa Laboratories Limited has a workforce of 367 employees on its EPFO records as of Apr 09, 2024, across 2 active EPFO establishments.

Employee count
367
Active EPFO establishments
2
Employee growth
2.8%

GST

Alpa Laboratories has 7 GST registrations: 4 active and 3 cancelled or inactive.

Total GSTINs
7
Active
4
Cancelled / inactive
3
GSTINStateStatusRegistered on
23AACCA8437C2Z2Madhya PradeshActive01 Jul 2017
09AACCA8437C2ZSUttar PradeshActive17 Sep 2020
36AACCA8437C1ZWTelanganaActive22 Sep 2020
10AACCA8437C2Z9BiharActive11 Nov 2020

To see the full GST registrations and return filing status of Alpa Laboratories Limited, buy the company report.

Recent activity

Alpa Laboratories Limited has 30 board changes on record since 1988: 20 appointments and 10 cessations. The latest: Pratik Shah was appointed as Director on 31 Aug 2024.

Filing
Alpa Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Gwalior.
AGM
Alpa Laboratories Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Cr with Charge ID 101142713 was registered on 23 Jul 2025.
Charges
A charge with Others of Rs. 14.00 Cr registered on 06 Dec 2017 with Charge ID 100139390 was modified on 03 Apr 2025.
Appointed
Pratik Shah was appointed as Director.
Ceased
Devendra Kumar Baheti ceased to be Director.
Ceased
Krishna Das Malani ceased to be Director.
Ceased
Sharadchandra Lunawat ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 100845955 was registered on 06 Jan 2024.
Appointed
Pratibha Lunawat was appointed as Director.
Appointed
Sanket Baheti was appointed as Director.
Appointed
Sunil Kumar Valecha was appointed as Director.

50 earlier events are in the company report.

News

Frequently asked questions

Alpa Laboratories is an active public limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 March 1988 (38+ years old) and is registered under CIN L85195MP1988PLC004446. Listed on BSE: 532878 and NSE: ALPA.

Alpa Laboratories reported revenue of ₹105.81 Cr for FY 2025-26 (down 5.9% YoY) based on consolidated financials.

Alpa Laboratories has 9 current directors:

The latest financial statements of Alpa Laboratories on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Alpa Laboratories is 23AACCA8437C2Z2, registered in Madhya Pradesh. The company has 7 GST registrations in all, of which 4 are active and 3 are cancelled or inactive. Other active GSTINs include 09AACCA8437C2ZS (Uttar Pradesh), 36AACCA8437C1ZW (Telangana), 10AACCA8437C2Z9 (Bihar).

The CIN (Corporate Identification Number) of Alpa Laboratories is L85195MP1988PLC004446. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Alpa Laboratories is a listed company as per MCA records. Its shares are listed on both BSE (code: 532878) and NSE (symbol: ALPA).

Alpa Laboratories has 39 court cases on record: 15 filed by the company and 24 filed against it. 4 are pending. Most are in the district courts.

Alpa Laboratories was incorporated on 18 March 1988, making it 38+ years old. It is registered with the Registrar of Companies, Gwalior.

Alpa Laboratories has 44 deals on record (42 market trades, 1 acquisition, 1 ipo); the latest was in September 2024.

The peers of Alpa Laboratories by revenue are Palsons Derma Private Limited, Maxwell Life Science Limited, Lewens Labs Private Limited, Naari Pharma Private Limited, Zenith Drugs Limited and 5 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Pratik Shah was appointed as Director on 31 Aug 2024. Devendra Kumar Baheti ceased to be Director on 31 Mar 2024. Krishna Das Malani ceased to be Director on 31 Mar 2024. Alpa Laboratories has 30 board changes on record in total.